This study explored the genetic variability in opioid receptor genes (OPRM1 and OPRD1) and their association with pain and adverse drug reactions (ADRs) in colorectal cancer patients in a Latin American Mestizo sample (Chileans). Here, OPRM1 is linked to colorectal cancer.